ACXP - Acurx Pharmaceuticals, Inc.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 2.07

Open

$ 2.11

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.11 - $ 2.11

52 Week Range

$ 1.17 - $ 8.82

Volume

28,608

Average Volume

Market Cap

26.23M

Beta (5Y Monthly)

$ 0.00

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-15-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	05-12-2023	03-31-2023	10-Q
5	03-15-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-12-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	03-16-2022	12-31-2021	10-K
10	11-12-2021	09-30-2021	10-Q
11	08-13-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Why Alcoa Shares Are Trading Higher; Here ...
04/18/2024 10:28:15

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
03/19/2024 17:31:02

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
03/19/2024 13:05:53

HC Wainwright & Co. Maintains Buy on Acurx...
03/19/2024 10:32:36

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
03/18/2024 21:33:12

Acurx Pharmaceuticals Inc Files For Common...
03/18/2024 20:08:48

Acurx Pharmaceuticals Q4 EPS $(0.37) Misse...
03/18/2024 11:04:11

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate ...

Earnings Scheduled For March 18, 2024
03/18/2024 09:57:15

Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.

A Preview Of Acurx Pharmaceuticals's Earnings
03/15/2024 14:01:19

HC Wainwright & Co. Reiterates Buy on Acur...
02/28/2024 17:53:47

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $14 price ta...

Acurx Announces FDA Has Granted An End Of ...
02/27/2024 12:11:01

Acurx Announces FDA Has Granted An End Of ...
02/27/2024 12:10:00

Acurx Reports Extended Clinical Cure Data ...
01/29/2024 12:06:15

This exploratory endpoint showed that 12 patients who agreed to be followed up to three months following Clinical Cure of their...

Acurx Announces Extended Clinical Cure Dat...
01/29/2024 12:02:49

why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Airspan Networks Shares Are Trading Hi...
01/17/2024 18:12:57

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
01/17/2024 17:31:12

why-is-antibiotic-player-acurx-pharmaceuticals-stock-trading-lower-today

Why Is Antibiotic Player Acurx Pharmaceuti...
01/17/2024 16:26:21

Acurx Pharmaceuticals' ibezapolstat outperforms vancomycin with a 94% eradication rate. Stay tuned for Q1 2024 updates on E...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
01/17/2024 13:05:58

Acurx Pharmaceuticals Announced Comparativ...
01/17/2024 12:06:36

HC Wainwright & Co. Maintains Buy on Acurx...
12/15/2023 11:36:34

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and raises the price target...